Anti-CDA antibody [EPR20525]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal CDA antibody. Suitable for WB, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 6 publications.
View Alternative Names
CDD, CDA, Cytidine deaminase, Cytidine aminohydrolase
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDA antibody [EPR20525] (AB222515)
Immunohistochemical analysis of paraffin-embedded human normal colon (panel A) and colon cancer (panel B) tissues labeling CDA with ab222515 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Cytoplasmic and nuclear staining on sporadic stromal cells of human normal colon tissue, while adjacent cancer cells and some stromal cells show moderate positive staining. The IHC signal on human colon cancer tissue was higher than its corresponding normal tissue (PMID : 9849491). Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDA antibody [EPR20525] (AB222515)
Immunohistochemical analysis of paraffin-embedded human normal liver (panel A) and liver cancer (panel B) tissues labeling CDA with ab222515 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Cytoplasmic and nuclear staining on normal human liver tissues, with only sporadic stromal cells showing positive staining in human liver cancer. The IHC signal on human liver cancer tissue was much lower than its corresponding normal tissue (PMID : 9849491). Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-CDA antibody [EPR20525] (AB222515)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol permeabilized HeLa (humanepithelialcell line from cervix adenocarcinoma) cell line labeling CDA with ab222515 at 1/70 dilution (red) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDA antibody [EPR20525] (AB222515)
Immunohistochemical analysis of paraffin-embedded human spleen tissue labeling CDA with ab222515 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Nuclear and cytoplasmic staining on neutrophils of human spleen (PMID : 11069255). Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-CDA antibody [EPR20525] (AB222515)
Western blot : Rabbit Monoclonal [EPR20525] to CDA ab222515 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta.
A band was observed at 16 kDa in Wild-type A549 cell lysates with no signal observed at this size in CDA knockout A549 cell line.
To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.
Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-CDA antibody [EPR20525] (ab222515) at 1/1000 dilution
Lane 1:
Wild-type A549 at 20 µg
Lane 2:
CDA knockout A549 at 20 µg
Lane 2:
Western blot - Human CDA knockout A549 cell line (<a href='/en-us/products/cell-lines/human-cda-knockout-a549-cell-line-ab300883'>ab300883</a>) at 20 µg
Lane 3:
Wild-type HCT at 20 µg
Lane 4:
CDA knockout HCT at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 16 kDa
Observed band size: 16 kDa
false
- WB
Lab
Western blot - Anti-CDA antibody [EPR20525] (AB222515)
Western blot : Rabbit Monoclonal [EPR20525] to CDA ab222515 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta.
A band was observed at 17 kDa in Wild-type HCT 116 cell lysates with no signal observed at this size in cda knockout HCT 116 cell line.
To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.
Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-CDA antibody [EPR20525] (ab222515) at 1/1000 dilution
Lane 1:
Wild-type HCT 116 at 20 µg
Lane 2:
CDA knockout HCT 116 at 20 µg
Lane 2:
Western blot - Human CDA knockout HCT116 cell line (ab300882) at 20 µg
Lane 3:
HepG2 at 20 µg
Lane 4:
MCF7 at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 16 kDa
Observed band size: 17 kDa
false
- WB
Supplier Data
Western blot - Anti-CDA antibody [EPR20525] (AB222515)
Exposure times : Lane 1 : 3 minutes; Lane 2 : 8 seconds; Lanes 3/5 : 5 seconds; Lane 4 : 30 seconds.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CDA antibody [EPR20525] (ab222515) at 1/1000 dilution
Lane 1:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg
Lane 2:
Human fetal spleen lysate at 10 µg
Lane 3:
HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg
Lane 4:
TF-1 (human bone marrow erythroleukemia cell line) whole cell lysate at 10 µg
Lane 5:
Human fetal kidney lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 16 kDa
Observed band size: 16 kDa
true
Related conjugates and formulations (1)
-
Anti-CDA antibody [EPR20525] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CDA enzyme influences the pyrimidine salvage pathway by facilitating nucleotide degradation and recycling. It operates independently rather than as part of a protein complex. The activity of this enzyme ensures a balanced nucleotide pool essential for DNA replication and repair processes. This balance affects cellular proliferation and survival highlighting the importance of studying CDA protein in normal physiology and various pathological conditions.
Pathways
CDA contributes significantly to pyrimidine metabolism and its recycling pathway. It maintains a connection with ribonucleotide reductase which plays a role in the regulation of deoxyribonucleotide pools during DNA synthesis. This interplay highlights the enzyme’s involvement in DNA repair pathways ensuring proper cell division and genomic integrity. Within these pathways enzymes like cytidine triphosphate synthetase also relate to CDA by participating in nucleotide homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
PloS one 20:e0331289 PubMed40892739
2025
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 16:1066 PubMed40504344
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37108401
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental & molecular medicine 54:1236-1249 PubMed35999456
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer 21:24 PubMed35045883
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:8127-8139 PubMed34350711
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com